http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Examines legislative proposals to promote the development of bioterrorism countermeasures by private companies, including Project BioShield, a proposal to encourage development of vaccines and treatments for potential bioterrorism agents such as anthrax and smallpox. Describes provisions of and examines issues related to S. 15, the Biodefense Improvement and Treatment of America Act.
Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC.
Library of Congress. Congressional Research Service.